Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MilliporeSigma™ TRA-1-60, Clone: TRA-1-60

Supplier:  MilliporeSigma™ MAB4360/DEL

Encompass

Catalog No. 50-175-526

Item Discontinued This item has been discontinued and is no longer available. Please reach out to your sales representative.


Description

Description

This antibody reacts with TRA-1-60 antigen that is expressed upon the surface of human teratocarcinoma stem cells (EC), human embryonic germ cells (EG) and human embryonic stem cells (ES). No immunoreactivity is seen with murine EC, EG or ES cells.Both the TRA-1-60 and TRA-1-81 monoclonal antibodies (MAB4381) recognize antigens that are associated with a pericellular matrix proteoglycan. TRA-1-60 reacts with a sialidase-sensitive epitope whilst TRA-1-81 reacts with an unknown epitope of the same molecule.

Andrews, P W, et al(1984). Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells.Hybridoma 3: 347-61

Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Western Blotting

Specifications

Specifications

TRA-1-60
1.18mg/mL
Mouse
100 μg
Stem Cell Biology
Human
IgM
Monoclonal
Unconjugated
Human embryonal carcinoma cell line 2102Ep
RUO
Primary
Semi-purified
Recommendations

Recommendations

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit